Literature DB >> 12054502

Mechanism of membrane depolarization caused by the Alzheimer Abeta1-42 peptide.

Barbara J Blanchard1, Veena L Thomas, Vernon M Ingram.   

Abstract

We report a novel observation that the neurotoxic Alzheimer peptide Abeta1-42, when pre-incubated, causes a dramatic and lasting membrane depolarization in differentiated human hNT neuronal cells and in rodent PC12 cells in a concentration-dependent manner. This phenomenon involves activation of the metabotropic glutamate receptor, mGluR(1). Abeta-induced membrane depolarization in PC12 cells is sensitive to mGluR(1) antagonists and to pertussis and cholera toxins, indicating the involvement of particular G-proteins. The effect is different from the known ability of aggregated Abeta1-42 to cause a calcium influx. Since mGluR(1) agonists mimic the Abeta effect, we deduce that in this cell system glutamate can control the membrane potential and thereby the excitability of its target neurons. We propose that Abeta-induced membrane depolarization described here leads in Alzheimer's disease to hyperexcitability of affected neurons and is a crucially important molecular mechanism for beta-amyloid toxicity and cognitive dysfunction in the disease. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054502     DOI: 10.1016/S0006-291X(02)00346-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Effect of sterols on beta-amyloid peptide (AbetaP 1-40) channel formation and their properties in planar lipid membranes.

Authors:  Silvia Micelli; Daniela Meleleo; Vittorio Picciarelli; Enrico Gallucci
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

Review 2.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

3.  "Nanosized voltmeter" enables cellular-wide electric field mapping.

Authors:  Katherine M Tyner; Raoul Kopelman; Martin A Philbert
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

4.  Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors.

Authors:  James H Chin; Li Ma; David MacTavish; Jack H Jhamandas
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

5.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

6.  Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy.

Authors:  Valerie Bomben; Jerrah Holth; John Reed; Paige Cramer; Gary Landreth; Jeffrey Noebels
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

Review 7.  The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease.

Authors:  Vicky W-W Tsai; Heather L Scott; Richard J Lewis; Peter R Dodd
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 8.  Cellular membrane fluidity in amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Grace Y Sun; Gunter P Eckert; James C-M Lee
Journal:  Mol Neurobiol       Date:  2014-02-20       Impact factor: 5.590

9.  Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule.

Authors:  Barbara J Blanchard; Albert Chen; Leslie M Rozeboom; Kate A Stafford; Peter Weigele; Vernon M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-23       Impact factor: 11.205

10.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.